Last reviewed · How we verify
dexamethasone 0.1%/povidone-iodine 0.4%
dexamethasone 0.1%/povidone-iodine 0.4% is a Corticosteroid Small molecule drug developed by University of Campinas, Brazil. It is currently in Phase 3 development for Preoperative preparation for cataract surgery. Also known as: Dexamethasone / Iodo - povidone.
Dexamethasone is a corticosteroid that suppresses inflammation and immune responses, while povidone-iodine has antimicrobial properties.
Dexamethasone is a corticosteroid that suppresses inflammation and immune responses, while povidone-iodine has antimicrobial properties. Used for Preoperative preparation for cataract surgery.
At a glance
| Generic name | dexamethasone 0.1%/povidone-iodine 0.4% |
|---|---|
| Also known as | Dexamethasone / Iodo - povidone |
| Sponsor | University of Campinas, Brazil |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
Dexamethasone works by inhibiting the production of pro-inflammatory cytokines and mediators, thereby reducing inflammation. Povidone-iodine, on the other hand, exerts its antimicrobial effects by releasing iodine, which disrupts microbial cell membranes and enzymes.
Approved indications
- Preoperative preparation for cataract surgery
Common side effects
- Increased intraocular pressure
Key clinical trials
- FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis (PHASE2)
- A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dexamethasone 0.1%/povidone-iodine 0.4% CI brief — competitive landscape report
- dexamethasone 0.1%/povidone-iodine 0.4% updates RSS · CI watch RSS
- University of Campinas, Brazil portfolio CI
Frequently asked questions about dexamethasone 0.1%/povidone-iodine 0.4%
What is dexamethasone 0.1%/povidone-iodine 0.4%?
How does dexamethasone 0.1%/povidone-iodine 0.4% work?
What is dexamethasone 0.1%/povidone-iodine 0.4% used for?
Who makes dexamethasone 0.1%/povidone-iodine 0.4%?
Is dexamethasone 0.1%/povidone-iodine 0.4% also known as anything else?
What drug class is dexamethasone 0.1%/povidone-iodine 0.4% in?
What development phase is dexamethasone 0.1%/povidone-iodine 0.4% in?
What are the side effects of dexamethasone 0.1%/povidone-iodine 0.4%?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: University of Campinas, Brazil — full pipeline
- Therapeutic area: All drugs in Ophthalmology
- Indication: Drugs for Preoperative preparation for cataract surgery
- Also known as: Dexamethasone / Iodo - povidone
- Compare: dexamethasone 0.1%/povidone-iodine 0.4% vs similar drugs
- Pricing: dexamethasone 0.1%/povidone-iodine 0.4% cost, discount & access